Resoconti Blueprint Medicines Corporation

Azioni

BPMC

US09627Y1091

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 26/04/2024			Variaz. 5gg	Var. 1 gen.
93 ^USD	+2,50%		+7,08%	+0,82%

25/04	Transcript : Blueprint Medicines Corporation - Special Call
22/03	L'insider di Blueprint Medicines ha venduto azioni per un valore di 2.188.265 dollari, secondo un recente deposito SEC	MT

Resoconti

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Transcript : Blueprint Medicines Corporation - Special Call	25/04
Transcript : Blueprint Medicines Corporation, Q4 2023 Earnings Call, Feb 15, 2024	15/02
Transcript : Blueprint Medicines Corporation Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 10:30 AM	08/01
Transcript : Blueprint Medicines Corporation, Q3 2023 Earnings Call, Oct 26, 2023	26/10/23
Transcript : Blueprint Medicines Corporation Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-11-2023 11:20 AM	11/09/23
Transcript : Blueprint Medicines Corporation, Q2 2023 Earnings Call, Aug 02, 2023	02/08/23
Transcript : Blueprint Medicines Corporation Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-14-2023 09:20 AM	14/06/23
Transcript : Blueprint Medicines Corporation - Special Call	22/05/23
Transcript : Blueprint Medicines Corporation, Q1 2023 Earnings Call, May 04, 2023	04/05/23
Transcript : Blueprint Medicines Corporation Presents at Barclays Global Healthcare Conference, Mar-15-2023 02:35 PM	15/03/23
Transcript : Blueprint Medicines Corporation - Special Call	27/02/23
Transcript : Blueprint Medicines Corporation, Q4 2022 Earnings Call, Feb 16, 2023	16/02/23
Transcript : Blueprint Medicines Corporation Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 04:30 PM	11/01/23
Transcript : Blueprint Medicines Corporation - Analyst/Investor Day	01/11/22
Blueprint Medicines Corporation fornisce una guida alle entrate per il 2022	01/11/22	CI
Transcript : Blueprint Medicines Corporation - Special Call	17/08/22
Transcript : Blueprint Medicines Corporation, Q2 2022 Earnings Call, Aug 02, 2022	02/08/22
Blueprint Medicines Corporation fornisce una guida alle entrate per il 2022	02/08/22	CI
Transcript : Blueprint Medicines Corporation - Special Call	30/06/22
Transcript : Blueprint Medicines Corporation Presents at Goldman Sachs 43rd Annual Global Healthcare Conference, Jun-16-2022 08:40 AM	16/06/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Resoconti Blueprint Medicines Corporation

Azioni

BPMC

US09627Y1091

Resoconti

Filtri